Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'gambogic acid 20172'

Search results for: 'gambogic acid 20172'

Items 31-40 of 62

Page
per page
  1. Mesalamine
    B1969 Mesalamine
    Summary: IKK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥7.65 mg/mL
  2. AH 7614
    B7792 AH 7614
     1 Citation
    Target: Free Fatty Acid Receptors
    Summary: FFA4/GPR120 antagonist
      ≥35.1 mg/mL
  3. Levomefolate calcium
    A3552 Levomefolate calcium
    Summary: Artificial form of folate
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  4. L-Mimosine
    B4751 L-Mimosine
    Target: Hydroxylases
    Summary: iron chelator and prolyl 4-hydroxylase inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥1.98 mg/mL
  5. Ranitidine
    B1564 Ranitidine
    Target: Histamine H2 Receptors
    Summary: Histamine H2-receptor antagonist
      ≥17.54 mg/mL
  6. Allopurinol
    A8360 Allopurinol
    Target: Xanthine oxidoreductases
    Summary: Xanthine oxidase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.15 mg/mL
  7. Taxifolin
    N1842 Taxifolin
    Target: AdipoR2|Opioid receptors
      insoluble in H2O; ≥13.8 mg/mL
  8. Elvitegravir (GS-9137)
    A4070 Elvitegravir (GS-9137)
    Target: HIV Integrases
    Summary: HIV-1 integrase inhibitor,potent
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
  9. Dioscin
    N1723 Dioscin
    Target: Autophagy
    Summary: Natural saponin with anti-tumor activities
      ≥35.55 mg/mL
  10. BMS 309403
    B7794 BMS 309403
     2 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL

Items 31-40 of 62

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 55item
  2. Natural Products 5item
Specificity
  1. Selective 44item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Proteasome 1 item
  2. Histone Deacetylases (HDACs) 4item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. Farnesoid X receptors (FXRs) 2item
  6. LPA Receptors 4item
  7. DOT1L 1 item
  8. Nrf2 1 item
  9. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  10. Neuraminidases (NA) 1 item
  11. RARs 4item
  12. Aminopeptidases 1 item
  13. FAK 3item
  14. Topoisomerases 1 item
  15. CREBBP 1 item
  16. EP300 1 item
  17. Pyk2 3item
  18. Calcium ionophores 1 item
  19. Insulin and Insulin-like Receptors 1 item
  20. AdipoR2 1 item
  21. Fatty-acid-binding proteins (FABPs) 1 item
  22. Free Fatty Acid Receptors 2item
  23. Autophagy 1 item
  24. Farnesyl Diphosphate Synthases 1 item
  25. HIV Integrases 1 item
  26. Calcium-activated chloride channels (CaCC) 1 item
  27. GPR35 1 item
  28. NPY Receptors 1 item
  29. RAR/RXR 1 item
  30. Opioid receptors 1 item
  31. Histamine H2 Receptors 1 item
  32. Monoamine oxidases (MAOs) 1 item
  33. TRP Channel 1 item
  34. Xanthine oxidoreductases 1 item
  35. fibrinolysis 1 item
  36. Hydroxylases 1 item
  37. Antioxidants 1 item
  38. GPR40 1 item
  39. PPAR 1 item
  40. GABA receptors 1 item
  41. HCV polymerase 1 item
  42. Vitamin D receptors (VDRs) 1 item
  43. EAA receptor 1 item
  44. HIV 1 item
  45. Histone Acetyltransferases (HATs) 1 item
  46. Pregnane X receptor(PXR) 1 item
  47. FAAH 1 item
  48. prolactin secretion 1 item
  49. gonadotropin release 1 item
  50. HMG 1 item
  51. HSD 1 item
  52. NS3/4a Proteases 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 1 item
  3. Bladder Cancer 1 item
  4. Brain Injuries Studies 1 item
  5. Breast Cancer 7item
  6. Cancer 23item
  7. Colon Cancer 2item
  8. Colorectal Cancer 3item
  9. Epilepsy 1 item
  10. Glioblastoma 1 item
  11. Glioma 2item
  12. HCV 1 item
  13. Hepatitis C 1 item
  14. Hepatocellular Carcinoma 3item
  15. HIV 1 item
  16. HIV Infections 2item
  17. Inflammation 1 item
  18. Inflammatory Diseases 1 item
  19. Influenza 1 item
  20. Lymphoma 1 item
  21. Melanoma 1 item
  22. Mixed Lineage Leukemia 1 item
  23. Multiple Myeloma 1 item
  24. Myeloma 1 item
  25. Non-small Cell Lung Cancer 1 item
  26. Ovarian Cancer 1 item
  27. Pain Relief 1 item
  28. Pancreatic Cancer 7item
  29. Pentacyclic Triterpenoid 1 item
  30. Prostate Cancer 4item
  31. Renal Cancer 1 item
  32. Renal Cell Carcinoma 2item
  33. Type 2 Diabetes 5item